Manufacturer record

Alves Healthcare Private Limited: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

13 batches manufactured by Alves Healthcare Private Limited (Himachal Pradesh) were declared Not of Standard Quality between August 2019 and August 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: AI22268, Adrenaline Injection I.P. Sterile 1 ml (exp Aug 2024). CDL Kolkata (CDSCO lab) found it not of standard quality: Description, Appearance of Solution, Particulate Matter & Assay. Listed in the August 2024 alert.

Records by type

13 records linked to Alves Healthcare Private Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
13Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Aug 2019 to Aug 2024

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

13
NSQ batches since 2019
9
Products affected
Assay
Most common failure
Aug 2024
Latest alert

Flagged batches per year

2019 · 12022 · 32023 · 82024 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Adrenaline Injection I.P. Sterile 1 ml Batch AI22268Mfg Sep 2022 · Exp Aug 2024 Description, Appearance of Solution, Particulate Matter & AssayAssay CDL KolkataCDSCO lab Aug 2024
Diclofenac Sodium Tablets IP 50 mg Batch AT22201Mfg Aug 2022 · Exp Jul 2024 Disintegratio nOther CDL KolkataCDSCO lab Sep 2023
Frusemide Injection IP (2ml) Batch AI22236Mfg Aug 2022 · Exp Jul 2024 pHpH CDL KolkataCDSCO lab Aug 2023
Erythromycin Stearate Tablets IP 250 mg Batch AT23118Mfg Apr 2023 · Exp Mar 2025 DissolutionDissolution CDL KolkataCDSCO lab Aug 2023
Rabeprazole Gastro-Resistant Tablets IP 20 mg Batch AT23029Mfg Feb 2023 · Exp Jan 2025 DissolutionDissolution CDL KolkataCDSCO lab Jul 2023
Erythromycin Stearate Tablets IP 250 mg Batch AT22356Mfg Dec 2022 · Exp Nov 2024 DissolutionDissolution CDL KolkataCDSCO lab Jun 2023
Doxycycline Capsules IP Batch AC22031Mfg Oct 2022 · Exp Sep 2024 AssayAssay CDL KolkataCDSCO lab May 2023
RANTIDINE HYDROCHLORIDE TABLETS IP 150 mg Batch AT22200Mfg Aug 2022 · Exp Jul 2024 Uniformity of WeightUniformity of weight/content CDTL HyderabadCDSCO lab Apr 2023
ALGLIMET M1 (Glimepiride 1 mg & Metformin 500 mg Tablets SR) Batch AT22068Mfg Mar 2022 · Exp Feb 2024 Assay and Dissolution of GlimepirideAssay CDTL KolkataCDSCO lab Mar 2023
Iron & Folic Acid Syrup IP, 50 ml. Batch AHL21015Mfg May 2021 · Exp Apr 2023 ?pH? and Identification & Assay of ?Folic Acid?Assay RDTL GuwahatiState lab Dec 2022
Iron & Folic Acid Syrup IP, 50 ml Batch AHL21034Mfg May 2021 · Exp Apr 2023 ?pH? and ?Identification & Assay of Folic Acid?Assay RDTL GuwahatiState lab Dec 2022
Iron & Folic Acid Syrup IP (50 ml) Batch AHL21012Mfg May 2021 · Exp Apr 2023 ?pH?, Identification & Assay of ?Folic Acid?Assay RDTL GuwahatiState lab Dec 2022
Frusemide Injection I.P. 2 ml Batch AI18064Mfg Jul 2018 · Exp Jun 2020 Extractable VolumeExtractable volume CDL KolkataCDSCO lab Aug 2019

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.